Swan Energy Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 30, 2025, 10:56 pm

Competitors of Swan Energy Ltd

All Competitor Stocks of Swan Energy Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:37 am

Below is a detailed analysis of the quarterly data for Swan Energy Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 856.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,908.00 Cr. (Dec 2024) to 856.00 Cr., marking a decrease of 1,052.00 Cr..
• For Expenses, as of Mar 2025, the value is 842.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,564.00 Cr. (Dec 2024) to 842.00 Cr., marking a decrease of 1,722.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from -656.00 Cr. (Dec 2024) to 14.00 Cr., marking an increase of 670.00 Cr..
• For OPM %, as of Mar 2025, the value is 2.00%. The value appears strong and on an upward trend. It has increased from -34.00% (Dec 2024) to 2.00%, marking an increase of 36.00%.
• For Other Income, as of Mar 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,869.00 Cr. (Dec 2024) to 24.00 Cr., marking a decrease of 1,845.00 Cr..
• For Interest, as of Mar 2025, the value is 23.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 45.00 Cr. (Dec 2024) to 23.00 Cr., marking a decrease of 22.00 Cr..
• For Depreciation, as of Mar 2025, the value is 31.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 61.00 Cr. (Dec 2024) to 31.00 Cr., marking a decrease of 30.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,107.00 Cr. (Dec 2024) to -15.00 Cr., marking a decrease of 1,122.00 Cr..
• For Tax %, as of Mar 2025, the value is 45.00%. The value appears to be improving (decreasing) as expected. It has decreased from 49.00% (Dec 2024) to 45.00%, marking a decrease of 4.00%.
• For Net Profit, as of Mar 2025, the value is -22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 562.00 Cr. (Dec 2024) to -22.00 Cr., marking a decrease of 584.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -0.57. The value appears to be declining and may need further review. It has decreased from 18.59 (Dec 2024) to -0.57, marking a decrease of 19.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:52 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:15 am

Below is a detailed analysis of the balance sheet data for Swan Energy Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 31.00 Cr..
• For Reserves, as of Mar 2025, the value is 7,311.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,248.00 Cr. (Mar 2024) to 7,311.00 Cr., marking an increase of 1,063.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,802.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 3,449.00 Cr. (Mar 2024) to 2,802.00 Cr., marking a decrease of 647.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 3,459.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,439.00 Cr. (Mar 2024) to 3,459.00 Cr., marking an increase of 1,020.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 13,604.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12,168.00 Cr. (Mar 2024) to 13,604.00 Cr., marking an increase of 1,436.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 3,734.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,148.00 Cr. (Mar 2024) to 3,734.00 Cr., marking a decrease of 414.00 Cr..
• For CWIP, as of Mar 2025, the value is 3,870.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,657.00 Cr. (Mar 2024) to 3,870.00 Cr., marking an increase of 213.00 Cr..
• For Investments, as of Mar 2025, the value is 668.00 Cr.. The value appears strong and on an upward trend. It has increased from 134.00 Cr. (Mar 2024) to 668.00 Cr., marking an increase of 534.00 Cr..
• For Other Assets, as of Mar 2025, the value is 5,331.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,229.00 Cr. (Mar 2024) to 5,331.00 Cr., marking an increase of 1,102.00 Cr..
• For Total Assets, as of Mar 2025, the value is 13,604.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,168.00 Cr. (Mar 2024) to 13,604.00 Cr., marking an increase of 1,436.00 Cr..

Notably, the Reserves (7,311.00 Cr.) exceed the Borrowings (2,802.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Swan Energy Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 28.83. This value is within the healthy range. It has increased from 22.34 (Mar 24) to 28.83, marking an increase of 6.49.
• For Diluted EPS (Rs.), as of Mar 25, the value is 28.83. This value is within the healthy range. It has increased from 22.34 (Mar 24) to 28.83, marking an increase of 6.49.
• For Cash EPS (Rs.), as of Mar 25, the value is 32.58. This value is within the healthy range. It has increased from 22.36 (Mar 24) to 32.58, marking an increase of 10.22.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 234.25. It has decreased from 255.98 (Mar 24) to 234.25, marking a decrease of 21.73.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 234.25. It has decreased from 255.98 (Mar 24) to 234.25, marking a decrease of 21.73.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 157.53. It has decreased from 160.06 (Mar 24) to 157.53, marking a decrease of 2.53.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 57.57. This value is within the healthy range. It has increased from 30.33 (Mar 24) to 57.57, marking an increase of 27.24.
• For PBIT / Share (Rs.), as of Mar 25, the value is 52.87. This value is within the healthy range. It has increased from 26.66 (Mar 24) to 52.87, marking an increase of 26.21.
• For PBT / Share (Rs.), as of Mar 25, the value is 46.87. This value is within the healthy range. It has increased from 19.44 (Mar 24) to 46.87, marking an increase of 27.43.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 27.88. This value is within the healthy range. It has increased from 18.69 (Mar 24) to 27.88, marking an increase of 9.19.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 24.10. This value is within the healthy range. It has increased from 9.61 (Mar 24) to 24.10, marking an increase of 14.49.
• For PBDIT Margin (%), as of Mar 25, the value is 36.54. This value is within the healthy range. It has increased from 18.94 (Mar 24) to 36.54, marking an increase of 17.60.
• For PBIT Margin (%), as of Mar 25, the value is 33.56. This value exceeds the healthy maximum of 20. It has increased from 16.65 (Mar 24) to 33.56, marking an increase of 16.91.
• For PBT Margin (%), as of Mar 25, the value is 29.75. This value is within the healthy range. It has increased from 12.14 (Mar 24) to 29.75, marking an increase of 17.61.
• For Net Profit Margin (%), as of Mar 25, the value is 17.69. This value exceeds the healthy maximum of 10. It has increased from 11.67 (Mar 24) to 17.69, marking an increase of 6.02.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.29. This value is within the healthy range. It has increased from 6.00 (Mar 24) to 15.29, marking an increase of 9.29.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.28. This value is below the healthy minimum of 15. It has increased from 4.79 (Mar 24) to 10.28, marking an increase of 5.49.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.19. This value is within the healthy range. It has increased from 7.70 (Mar 24) to 15.19, marking an increase of 7.49.
• For Return On Assets (%), as of Mar 25, the value is 5.55. This value is within the healthy range. It has increased from 2.47 (Mar 24) to 5.55, marking an increase of 3.08.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.40 (Mar 24) to 0.22, marking a decrease of 0.18.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.38. This value is within the healthy range. It has decreased from 0.54 (Mar 24) to 0.38, marking a decrease of 0.16.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.38. It has decreased from 0.44 (Mar 24) to 0.38, marking a decrease of 0.06.
• For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 3.13 (Mar 24) to 2.14, marking a decrease of 0.99.
• For Quick Ratio (X), as of Mar 25, the value is 1.52. This value is within the healthy range. It has decreased from 2.95 (Mar 24) to 1.52, marking a decrease of 1.43.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.37. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 4.37, marking an increase of 3.55.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.89 (Mar 24) to 0.00, marking a decrease of 0.89.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.64 (Mar 24) to 0.00, marking a decrease of 0.64.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.11 (Mar 24) to 0.00, marking a decrease of 99.11.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.36 (Mar 24) to 0.00, marking a decrease of 99.36.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 9.72. This value is within the healthy range. It has increased from 4.20 (Mar 24) to 9.72, marking an increase of 5.52.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.72. This value is within the healthy range. It has increased from 3.59 (Mar 24) to 5.72, marking an increase of 2.13.
• For Enterprise Value (Cr.), as of Mar 25, the value is 16,279.98. It has decreased from 24,843.48 (Mar 24) to 16,279.98, marking a decrease of 8,563.50.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.30. This value exceeds the healthy maximum of 3. It has decreased from 4.95 (Mar 24) to 3.30, marking a decrease of 1.65.
• For EV / EBITDA (X), as of Mar 25, the value is 9.02. This value is within the healthy range. It has decreased from 26.13 (Mar 24) to 9.02, marking a decrease of 17.11.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.73. This value is within the healthy range. It has decreased from 4.18 (Mar 24) to 2.73, marking a decrease of 1.45.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 99.10 (Mar 24) to 0.00, marking a decrease of 99.10.
• For Price / BV (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has decreased from 3.34 (Mar 24) to 1.84, marking a decrease of 1.50.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.73. This value is within the healthy range. It has decreased from 4.18 (Mar 24) to 2.73, marking a decrease of 1.45.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.05, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness